Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The use of nirmatrelvir–ritonavir (Paxlovid) is associated with a lower risk for death or hospitalization in extremely vulnerable patients with COVID-19. Low-risk patients do not appear to benefit.
Novavax's Covid shot is arriving nearly three weeks after new jabs from Pfizer and Moderna reached Americans — but analysts aren't worried about that delay.
By Adriano Marchese Moderna has filed a new drug submission to Canadian health regulators for an investigational vaccine aimed at preventing RSV in older...
Around 4 million Americans received the updated COVID-19 shots in September, even as some people have found it difficult to book vaccination appointments or find the vaccines at no cost.
The combination vaccine has acceptable side effects and could be ready to launch as early as 2025, according to Moderna.